Of the four biomarkers we detected, ESR1 is the only one in common with the reported signature for luminal breast cancers (ESR1, GATA3, FOXA1, XBP1, and cMYB) (Cancer Genome Atlas, 2012). This evidence concerns the gene XBP1 and breast carcinoma.